Hansa Biopharma AB
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-07-22
Analyst
ABG
Equibles does not estimate personal net worth.
Georg Digolinov-Bjerki is recorded as Analyst at ABG. Georg Digolinov-Bjerki has spoken on 1 earnings call across 1 company, most recently for Hansa Biopharma AB on July 22, 2026. The companies whose calls Georg Digolinov-Bjerki spoke on are classified in the Healthcare sector.
“I am wondering, now that the CERB deal has formally been closed, if perhaps you're able to provide some details on the terms in the supply agreement of IDFERICS, please?”
ABG
Analyst
Transcript header (unverified)
Hansa Biopharma AB
Biotechnology · Healthcare
Interim Report January-June 2026 Conference Call
Hansa Biopharma AB